You appear to have JavaScript disabled in your browser.
PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you.
How do I enable JavaScript?
Common symptoms
How bad it is
What people are taking for it
Severity
Severe
Moderate
Mild
None
Anxious mood
1 (8%) patients experienced severe severity
2 (15%) patients experienced moderate severity
5 (38%) patients experienced mild severity
5 (38%) patients experienced no severity
Clonazepam , Escitalopram , Fluoxetine
Pain
2 (15%) patients experienced severe severity
5 (38%) patients experienced moderate severity
4 (31%) patients experienced mild severity
2 (15%) patients experienced no severity
Hydrocodone-Acetaminophen , Cyclobenzaprine , Meloxicam
Insomnia
1 (8%) patients experienced severe severity
0 (0%) patients experienced moderate severity
5 (38%) patients experienced mild severity
7 (54%) patients experienced no severity
Doxepin , Amitriptyline , Diphenhydramine
Blurry vision
0 (0%) patients experienced severe severity
2 (29%) patients experienced moderate severity
3 (43%) patients experienced mild severity
2 (29%) patients experienced no severity
dorzolamide ophthalmic
Fatigue
5 (38%) patients experienced severe severity
1 (8%) patients experienced moderate severity
5 (38%) patients experienced mild severity
2 (15%) patients experienced no severity
Modafinil
Depressed mood
2 (15%) patients experienced severe severity
2 (15%) patients experienced moderate severity
5 (38%) patients experienced mild severity
4 (31%) patients experienced no severity
Escitalopram , Citalopram , Sertraline
Treatments reported by members
Perceived effectiveness
Overall rating of side effects
# of Evaluations
1 (100%) experienced major perceived effectiveness
0 (0%) experienced moderate perceived effectiveness
0 (0%) experienced slight perceived effectiveness
0 (0%) experienced no perceived effectiveness
1 (100%) experienced severe side effects
0 (0%) experienced moderate side effects
0 (0%) experienced mild side effects
0 (0%) experienced no side effects
1
0 (NaN%) experienced major perceived effectiveness
0 (NaN%) experienced moderate perceived effectiveness
0 (NaN%) experienced slight perceived effectiveness
0 (NaN%) experienced no perceived effectiveness
0 (NaN%) experienced severe side effects
0 (NaN%) experienced moderate side effects
0 (NaN%) experienced mild side effects
0 (NaN%) experienced no side effects
0
0 (NaN%) experienced major perceived effectiveness
0 (NaN%) experienced moderate perceived effectiveness
0 (NaN%) experienced slight perceived effectiveness
0 (NaN%) experienced no perceived effectiveness
0 (NaN%) experienced severe side effects
0 (NaN%) experienced moderate side effects
0 (NaN%) experienced mild side effects
0 (NaN%) experienced no side effects
0
0 (NaN%) experienced major perceived effectiveness
0 (NaN%) experienced moderate perceived effectiveness
0 (NaN%) experienced slight perceived effectiveness
0 (NaN%) experienced no perceived effectiveness
0 (NaN%) experienced severe side effects
0 (NaN%) experienced moderate side effects
0 (NaN%) experienced mild side effects
0 (NaN%) experienced no side effects
0
0 (NaN%) experienced major perceived effectiveness
0 (NaN%) experienced moderate perceived effectiveness
0 (NaN%) experienced slight perceived effectiveness
0 (NaN%) experienced no perceived effectiveness
0 (NaN%) experienced severe side effects
0 (NaN%) experienced moderate side effects
0 (NaN%) experienced mild side effects
0 (NaN%) experienced no side effects
0
<20
20s
30s
40s
50s
60s
70+
Current Age
Distribution of females vs. males
Gender
79%
Females
21%
Males
Age at first symptom
Age at first symptom
# of patients
Proportion
0-19 years
2
20-29 years
3
30-39 years
7
40-49 years
2
50-59 years
2
60-69 years
0
70+ years
0
Diagnosis status
Diagnosis status
# of patients
Proportion
Diagnosed
22
Last updated:
June 20, 2013